DBV TECHNOLOGIES |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.198 EUR | +4.90% |
|
-3.55% | -35.32% |
| May. 31 | European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower | MT |
| May. 31 | DBV Technologies Says ADS Ratio Change to be Effective June 7 | MT |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-07-28
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.142
EUR
Average target price
9.467
EUR
Spread / Average Target
+728.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.24% | 119M | |
| +15.54% | 78.51B | |
| +13.10% | 9B | |
| +58.17% | 4.96B | |
| -14.94% | 4.84B | |
| -.--% | 3.72B | |
| -26.63% | 2.19B | |
| +16.75% | 2.12B | |
| -37.97% | 1.94B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- DBV Stock
- Funds and ETFs DBV Technologies
